3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
2
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Mesothelioma, Malignant
1
Interventions
Pemetrexed
4
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Interleukin-2
3
Carboplatin
3
atezolizumab
2
aldesleukin
2
Pharmaceutical Preparations
2
Ipilimumab
2
olaparib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
Thoracoscopy
1
Thoracic Surgery, Video-Assisted
1
Surgery, Computer-Assisted
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Injections
1
Influenza Vaccines
1
Indocyanine Green
1
In Situ Hybridization, Fluorescence
1
Cyclophosphamide
1
Combined Modality Therapy
1
Cerebral Decortication
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mesothelioma, Malignant
×
Cerebral Decortication
×
Clear all
NCT07121374
2025-08-13
NECIM
University Hospital, Antwerp
Phase 1/2
Recruiting
37 enrolled